Patterns of Peri-Gestational Weight Change Among Women Living with HIV in Nigeria Receiving Dolutegravir Compared to Alternative Antiretroviral Regimens: A Retrospective Cohort Study

This retrospective cohort study examines peri-gestational weight changes among women living with HIV in Nigeria receiving dolutegravir-based antiretroviral therapy compared with alternative treatment regimens. The authors analyze maternal weight trajectories during pregnancy to assess potential associations between antiretroviral treatment type and gestational weight outcomes. The findings contribute to understanding the metabolic and maternal health effects of dolutegravir use in pregnancy and inform clinical guidance for HIV treatment among pregnant women in resource-limited settings.